These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29576599)

  • 1. New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.
    Yanase T; Oki Y; Katabami T; Otsuki M; Kageyama K; Tanaka T; Kawate H; Tanabe M; Doi M; Akehi Y; Ichijo T
    Endocr J; 2018 Apr; 65(4):383-393. PubMed ID: 29576599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed diagnostic criteria for subclinical Cushing's syndrome associated with adrenal incidentaloma.
    Akehi Y; Kawate H; Murase K; Nagaishi R; Nomiyama T; Nomura M; Takayanagi R; Yanase T
    Endocr J; 2013; 60(7):903-12. PubMed ID: 23574729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of cortisol/ACTH ratio (CAR) for diagnosis of cushing's syndrome: comparison of CAR with findings in dexamethasone suppression test.
    Iwamoto Y; Tatsumi F; Itoh T; Sasaki T; Mori S; Sugisaki T; Nakao E; Ohnishi M; Kusano T; Takenouchi H; Iwamoto H; Sanada J; Fushimi Y; Katakura Y; Kimura T; Shimoda M; Nakanishi S; Kaku K; Mune T; Kaneto H
    Sci Rep; 2022 Oct; 12(1):17680. PubMed ID: 36271288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the diagnostic criteria for Cushing's disease in Japan.
    Kageyama K; Oki Y; Sakihara S; Nigawara T; Terui K; Suda T
    Endocr J; 2013; 60(2):127-35. PubMed ID: 23171704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome.
    Abe I; Sugimoto K; Miyajima T; Ide T; Minezaki M; Takeshita K; Takahara S; Nakagawa M; Fujimura Y; Kudo T; Miyajima S; Taira H; Ohe K; Ishii T; Yanase T; Kobayashi K
    Intern Med; 2018 Sep; 57(17):2467-2472. PubMed ID: 29709936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of diagnostic tests for ACTH-dependent Cushing's syndrome.
    Suda T; Kageyama K; Nigawara T; Sakihara S
    Endocr J; 2009; 56(3):469-76. PubMed ID: 19225213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
    Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
    J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which type 2 diabetes mellitus patients should be screened for subclinical Cushing's syndrome?
    Cansu GB; Atılgan S; Balcı MK; Sarı R; Özdem S; Altunbaş HA
    Hormones (Athens); 2017 Jan; 16(1):22-32. PubMed ID: 28500825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing's disease from pseudo-Cushing's syndrome.
    Gatta B; Chabre O; Cortet C; Martinie M; Corcuff JB; Roger P; Tabarin A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4290-3. PubMed ID: 17635947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
    Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
    Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the 1 mg overnight dexamethasone suppression test in the diagnosis of the subclinical Cushing's syndrome in patients with Adrenal Incidentaloma].
    Li L; Han B; Dou J; Yang G; Gu W; Lü Z; Mu Y
    Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(48):3912-6. PubMed ID: 27122212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancies in results of low-and high-dose dexamethasone suppression tests for diagnosing preclinical Cushing's syndrome.
    Katabami T; Obi R; Shirai N; Naito S; Saito N
    Endocr J; 2005 Aug; 52(4):463-9. PubMed ID: 16127216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.